Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06401746
What this trial is testing

Body Surface Gastric Mapping in Patients on Semaglutide

Who this might be right for
Semaglutide-Induced Gastric MotilityGastroparesis
University of Western Sydney 9
Post-approval studies (Phase 4)UnknownNCT01435980
What this trial is testing

Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Wu Qinan 60
Not applicableLooking for participantsNCT07019519
What this trial is testing

POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

Who this might be right for
Postural Orthostatic Tachycardia Syndrome (POTS)Healthy
University of Copenhagen 30
Not applicableEnrolling By InvitationNCT07234916
What this trial is testing

Multivitamin Impact on Micronutrient Status in GLP-1 Users: A Randomized Trial

Who this might be right for
Weight LossNutritional DeficienciesGLP - 1+1 more
Erasmus Medical Center 246
Not applicableStudy completedNCT06118203
What this trial is testing

Semaglutide Use in Acute Pulmonary Embolism

Who this might be right for
Pulmonary Embolism
Imperial College London 18
Not applicableNot Yet RecruitingNCT07771166
What this trial is testing

Effects of N-Acyl Taurines on Incretin Levels in Healthy Subjects

Who this might be right for
Cardiometabolic Conditions
University Hospital, Gentofte, Copenhagen 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07613437
What this trial is testing

GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial

Who this might be right for
Intracerebral Hemorrhage
Chinese University of Hong Kong 200
Not applicableStudy completedNCT01740921
What this trial is testing

GLP-1 and Microvascular Function in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Royal Devon and Exeter NHS Foundation Trust 39
Early research (Phase 1)Study completedNCT02749032
What this trial is testing

Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion

Who this might be right for
Type 2 Diabetes
Michael A. Nauck 24
Not applicableStudy completedNCT01607931
What this trial is testing

Exercise, Glucose Kinetics, and the Incretin Effect

Who this might be right for
Type 2 Diabetes
Rigshospitalet, Denmark 12
Early research (Phase 1)Study completedNCT02084251
What this trial is testing

Clinical Trial for PB-119 in Healthy Subjects (Phase I)

Who this might be right for
Type II Diabetes
PegBio Co., Ltd. 70
Not applicableStudy completedNCT02264951
What this trial is testing

Fat-induced Release of GLP-1 in Humans

Who this might be right for
Type 2 Diabetes
Glostrup University Hospital, Copenhagen 12
Not applicableStudy completedNCT03129594
What this trial is testing

Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction

Who this might be right for
Coronary AngiographyGlucagon-like Peptide-1
Chinese PLA General Hospital 709
Post-approval studies (Phase 4)Study completedNCT05659537
What this trial is testing

Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 212
Post-approval studies (Phase 4)Ended earlyNCT01381926
What this trial is testing

Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist

Who this might be right for
Type 2 Diabetes MellitusBone Remodeling
University of Alabama at Birmingham 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07511543
What this trial is testing

Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy

Who this might be right for
Ischemic Stroke
Population Health Research Institute 100
Not applicableLooking for participantsNCT07540949
What this trial is testing

Rutazyme Lemon Fermented Product Capsules for Metabolic Function in Adults With Obesity

Who this might be right for
ObesityMetabolic Syndrome
National Taiwan Sport University 40
Not applicableStudy completedNCT07194317
What this trial is testing

A Feasibility Study to Determine the Most Appropriate Digital Dietary Assessment Tool in Patients With Obesity Initiating GLP-1 Receptor Agonist Treatment

Who this might be right for
Obese Patients
King's College London 64
Large-scale testing (Phase 3)Not Yet RecruitingNCT07806851
What this trial is testing

UBT251 Injection Phase Ⅲ Study (OSA-PAP)

Who this might be right for
Obstructive Sleep ApneaObesity
The United Bio-Technology (Hengqin) Co., Ltd. 150
Not applicableStudy completedNCT06790771
What this trial is testing

Effect of Supplement on Appetite and GLP-1

Who this might be right for
Hunger
Texas Christian University 25
Next Page